These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Kinetic model for NS1643 drug activation of WT and L529I variants of Kv11.1 (hERG1) potassium channel. Perissinotti LL, Guo J, De Biase PM, Clancy CE, Duff HJ, Noskov SY. Biophys J; 2015 Mar 24; 108(6):1414-1424. PubMed ID: 25809254 [Abstract] [Full Text] [Related]
10. Activation of ERG2 potassium channels by the diphenylurea NS1643. Elmedyb P, Olesen SP, Grunnet M. Neuropharmacology; 2007 Aug 24; 53(2):283-94. PubMed ID: 17610913 [Abstract] [Full Text] [Related]
11. Effects of Temperature on Heteromeric Kv11.1a/1b and Kv11.3 Channels. Mauerhöfer M, Bauer CK. Biophys J; 2016 Aug 09; 111(3):504-523. PubMed ID: 27508435 [Abstract] [Full Text] [Related]
12. Probing the binding sites and mechanisms of action of two human ether-a-go-go-related gene channel activators, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243). Xu X, Recanatini M, Roberti M, Tseng GN. Mol Pharmacol; 2008 Jun 09; 73(6):1709-21. PubMed ID: 18372399 [Abstract] [Full Text] [Related]
14. NS1643 interacts around L529 of hERG to alter voltage sensor movement on the path to activation. Guo J, Cheng YM, Lees-Miller JP, Perissinotti LL, Claydon TW, Hull CM, Thouta S, Roach DE, Durdagi S, Noskov SY, Duff HJ. Biophys J; 2015 Mar 24; 108(6):1400-1413. PubMed ID: 25809253 [Abstract] [Full Text] [Related]
15. Structure-guided topographic mapping and mutagenesis to elucidate binding sites for the human ether-a-go-go-related gene 1 potassium channel (KCNH2) activator NS1643. Durdagi S, Guo J, Lees-Miller JP, Noskov SY, Duff HJ. J Pharmacol Exp Ther; 2012 Aug 24; 342(2):441-52. PubMed ID: 22573844 [Abstract] [Full Text] [Related]
16. Computational analysis of the effects of the hERG channel opener NS1643 in a human ventricular cell model. Peitersen T, Grunnet M, Benson AP, Holden AV, Holstein-Rathlou NH, Olesen SP. Heart Rhythm; 2008 May 24; 5(5):734-41. PubMed ID: 18452879 [Abstract] [Full Text] [Related]
17. Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbits. Bentzen BH, Bahrke S, Wu K, Larsen AP, Odening KE, Franke G, Storm vańs Gravesande K, Biermann J, Peng X, Koren G, Zehender M, Bode C, Grunnet M, Brunner M. J Cardiovasc Pharmacol; 2011 Feb 24; 57(2):223-30. PubMed ID: 21135701 [Abstract] [Full Text] [Related]
18. Pharmacological rescue of hERG currents carried out by G604S and wide type hERG co-expression. Huo J, Zhang A, Guo X, Qiang H, Liu P, Bai L, Ma A. Clin Exp Pharmacol Physiol; 2016 Sep 24; 43(9):851-61. PubMed ID: 27199074 [Abstract] [Full Text] [Related]
19. Enhancement of HERG K+ currents by Cd2+ destabilization of the inactivated state. Johnson JP, Balser JR, Bennett PB. Biophys J; 1999 Nov 24; 77(5):2534-41. PubMed ID: 10545354 [Abstract] [Full Text] [Related]